These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4637423)

  • 1. [Mechanism of action of biguanides, with special reference to phenethylbiguanide, in the human being].
    Wajchenberg BL; Halpern A; Shnaider J
    Acta Diabetol Lat; 1972; 9(2):237-62. PubMed ID: 4637423
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes mellitus and obesity: phenformin hydrochloride as a research tool. Concluding remarks.
    Danowski TS
    Ann N Y Acad Sci; 1968 Mar; 148(3):958-62. PubMed ID: 5241487
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucose kinetics before and after phenformin in the human subject.
    Searle GL; Cavalieri RR
    Ann N Y Acad Sci; 1968 Mar; 148(3):734-42. PubMed ID: 5241472
    [No Abstract]   [Full Text] [Related]  

  • 4. Inter-relationship between insulin secretion and plasma free fatty acid and triglyceride transport kinetics in maturity onset diabetes and the effect of phenethylbiguanide (phenformin).
    Kissebah AH; Adams PW; Wynn V
    Diabetologia; 1974 Apr; 10(2):119-30. PubMed ID: 4844187
    [No Abstract]   [Full Text] [Related]  

  • 5. Biguanides and lactate metabolism: a review.
    Hermann LS
    Dan Med Bull; 1973 Jun; 20(3):65-79. PubMed ID: 4594325
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinetics of glucose utilization in obesity: the effect of phenformin.
    Kreisberg RA
    Ann N Y Acad Sci; 1968 Mar; 148(3):743-55. PubMed ID: 5241473
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of phenformin on gluconeogenesis from lactate and intracellular pH in the isolated perfused guinea pig liver.
    Lloyd MH; Iles RA; Walton B; Hamilton CA; Cohen RD
    Diabetes; 1975 Jul; 24(7):618-24. PubMed ID: 239872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Animal experimental studies on the mode of action of biguanides. 1. Studies on non hypoglycemically acting biguanide].
    Losert W; Schillinger E; Kraaz W; Loge O; Jahn P
    Arzneimittelforschung; 1972 Sep; 22(9):1540-52. PubMed ID: 4678618
    [No Abstract]   [Full Text] [Related]  

  • 9. [Animal experimental studies on the mode of action of biguanides. 1. Studies with hypoglycemia-inducing doses of biguanide].
    Losert W; Schillinger E; Kraaz W; Loge O; Jahn P
    Arzneimittelforschung; 1972 Jul; 22(7):1157-69. PubMed ID: 4678123
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of action of phenethylbiguanide (phenformin) in man. III. interrelationship between ethanol and phenethylibiguanide (PBG) in normal and diabetic subjects.
    Wajchenberg BL; Halpern A; Leme CE; Lerário AC; Silveria AA; Fioratti PA; Cesar FP
    Metabolism; 1976 Sep; 25(9):957-71. PubMed ID: 958002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective, hypoglycemic agent, with the biguanides.
    Tutwiler GF; Bridi G
    Diabetes; 1978 Aug; 27(8):868-76. PubMed ID: 680413
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects and adverse effects of antidiabetic derivatives of biguanide].
    Czyzyk A
    Med Welt; 1975 Oct; 26(42):1928-36. PubMed ID: 1102836
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism of action of phenethylbiguanide (Phenformin) in man IV. Effect of phenethylbiguanide (PBG) on glucose tolerance and lactate dynamics in obese nondiabetic and chemical diabetic subjects.
    Cesar FP; Leme CE; Ohnuma LY; Palomino CR; Wajchenberg BL
    Metabolism; 1980 Mar; 29(3):270-8. PubMed ID: 6990168
    [No Abstract]   [Full Text] [Related]  

  • 14. Differences between metabolic responses to fasting in obese diabetic and obese nondiabetic subjects.
    Jackson RA; Moloney M; Lowy C; Wright AD; Hartog M; Pilkington TR; Fraser TR
    Diabetes; 1971 Apr; 20(4):214-27. PubMed ID: 4927927
    [No Abstract]   [Full Text] [Related]  

  • 15. On the mechanism of action of biguanides. evidence against an inhibition of gluconeogenesis from protein in normal fasting subjects.
    Göschke H; Kaufmann U; Thölen H; Berger W
    Horm Metab Res; 1978 Jan; 10(1):1-4. PubMed ID: 631733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of phenetylbiguanide (phenformin) in normal subjects. II. Intestinal absorption versus nonintestinal effects.
    Halpern A; Wajchenberg BL; Fazia AI
    Metabolism; 1974 Apr; 23(4):349-58. PubMed ID: 4817364
    [No Abstract]   [Full Text] [Related]  

  • 17. Glucose metabolism in normal and obese subjects. Effect of phenformin.
    Kreisberg RA
    Diabetes; 1968 Aug; 17(8):481-8. PubMed ID: 5668011
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of phenformin on fat and lactate metabolism and insulin production in starved normal subjects.
    Lyngsoe J; Bitsch V; Trap-Jensen J
    Metabolism; 1972 Mar; 21(3):179-86. PubMed ID: 5060759
    [No Abstract]   [Full Text] [Related]  

  • 19. Lactate turnover and gluconeogenesis in obesity. Effect of phenformin.
    Kreisberg RA; Pennington LF; Boshell BR
    Diabetes; 1970 Jan; 19(1):64-9. PubMed ID: 5410104
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperlacticacidemia in man: ethanol-phenformin synergism.
    Kreisberg RA; Owen WC; Siegal AM
    J Clin Endocrinol Metab; 1972 Jan; 34(1):29-35. PubMed ID: 4550330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.